Login

DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Noxopharm details science-driven strategy in new investor presentation - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:00:00
Jesse D. Bracamonte, D.O.
00:10:00
Bokusgruppen's CEO Maria Edsman on Latest Quarterly Report and Future Priorities | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
DCC's Donal Murphy Addresses Annual Results: Insights and Highlights | Donal Murphy - CEO of DCC plc
00:10:00
Alex Biggs Discusses Promising Drill Results at Mavis Lake and PDAC Highlights
00:10:00
Insights on Asia's Economic Landscape with Mike from Henderson Far East Income Ltd
00:10:00
Journey of Growth: The Rise of Gemini Solutions
00:10:00
Why I Chose Financial Planning: My Journey and Passion
00:10:00
Atlas Copco CEO on Energy Efficiency and Climate Action | Mats Rahmström, President, Atlas Copco Group.
00:10:00
Exploring the Future of Smart Cities: Interview with Rob Mostert at the ICANN Conference in Madrid
00:10:00
Entrepreneurs launching game-changing startups in sports betting|Jon Powell,Managing Partner,SeventySix Capital
00:10:00
An interview featured in the G-Research Distinguished Speaker Series.

© 2017 - Neuhu+